IXEMPRA

Marca svizra · 526425 · Marca da pled · En vigur

Inscripziun en il register

Numer da registraziun
526425
Numer da la dumonda
55477/2004
Status
En vigur
Tip
Marca da pled
Deponida
16-08-2004
Registrada
05-10-2004
Publitgada
19-10-2004
Protegida fin ils
16-08-2034
Prioritad
29.03.2004 US
Lingua da la procedura
tudestg
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Pharmazeutische Präparate zur Anwendung beim Menschen.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 05-07-2024

    Prolungà

    Published in Swissreg on 05.07.2024

  2. 17-05-2016

    Transferì

    Owner
    Bristol-Myers Squibb Company, 345 Park Avenue, NY 10154 New York, USA → R-PHARM US OPERATING, LLC, 3120 Princeton Pike, Suite 301, Lawrence, New Jersey 08648, USA
    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Dr. Michael Kikinis, Waffenplatzstrasse 10, 8002 Zürich

    Published in Swissreg on 17.05.2016

  3. 05-03-2014

    Prolungà

    Published in Swissreg on 05.03.2014

  4. 10-12-2007

    Adressa dal represchentant midada

    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 239 of 10.12.2007

  5. 19-10-2004

    Registrà

    Published in the SOGC no. 203 of 19.10.2004

Partidas

Possessura

R-PHARM US OPERATING, LLC

3120 Princeton Pike Suite 301, Lawrence, New Jersey 08648, US

Represententa

Dr. Michael Kikinis

8002 Zürich

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.